Vivani Medical (VANI) awards CEO 200K stock options and 100K RSUs
Rhea-AI Filing Summary
Vivani Medical, Inc. granted Chief Executive Officer Adam Mendelsohn 200,000 stock options and 100,000 performance-based RSUs on July 28, 2026. The options have a $1.31 exercise price, a 10-year term, and vest 25% after one year then monthly for 36 months. Each RSU equals one share and vests in three stages tied to Vivani's stock trading at or above $3.15 for three consecutive trading days, with additional tranches one and two years after that date; the RSUs expire if this price condition is not met within four years and all vesting requires continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Mendelsohn Adam
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock Option F1 | 200,000 | $0.00 | $0.00 |
| Grant/Award | RSUs F2, F3 | 100,000 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock Option — 200,000 shares (Direct);
RSUs — 100,000 shares (Direct)
Footnotes (3)
- F1. The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.
- F2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.
- F3. The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.
Key Figures
Stock options granted: 200,000 shares
Option exercise price: $1.31 per share
Option term: 10 years
+2 more
5 metrics
Stock options granted
200,000 shares
Common Stock Options granted to CEO on 2026-07-28
Option exercise price
$1.31 per share
Exercise price for 200,000 stock options
Option term
10 years
Term of CEO stock options expiring 2036-07-27
RSUs granted
100,000 units
Performance-based restricted stock units granted to CEO
RSU price hurdle
$3.15 per share
Stock-price condition for RSU vesting over three trading days
Key Terms
restricted stock unit ("RSU"), performance based RSUs, contingent right to receive one share, vesting date
4 terms
restricted stock unit ("RSU") financial
"Each restricted stock unit ("RSU") represents a contingent right"
performance based RSUs financial
"The performance based RSUs shall vest in three stages"
vesting date financial
"subject to continued service through each applicable vesting date"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did Vivani Medical (VANI) grant to CEO Adam Mendelsohn?
Vivani Medical granted CEO Adam Mendelsohn 200,000 stock options and 100,000 performance-based RSUs on July 28, 2026. The options have a $1.31 exercise price, and both awards involve multi-year vesting tied to service and, for RSUs, share-price performance.
What are the key terms of Adam Mendelsohn's 200,000 Vivani (VANI) stock options?
The grant covers 200,000 Vivani common stock options with a $1.31 exercise price and a 10-year term, expiring July 27, 2036. Vesting is 25% after one year of service, then monthly vesting over the following 36 months, subject to continued employment.
How do the 100,000 performance-based RSUs for Vivani (VANI) CEO vest?
The 100,000 RSUs vest in three equal stages. One-third vests when Vivani's stock trades at or above $3.15 for three consecutive trading days, the next third one year later, and the final third one year after that, all requiring continued service.
What stock-price hurdle applies to Vivani (VANI) CEO Adam Mendelsohn's RSUs?
The performance condition requires Vivani's stock to be at or above $3.15 for three consecutive trading days within four years of the grant. If this hurdle is not met in that period, the 100,000 RSUs expire without vesting.
Does Adam Mendelsohn's latest Vivani (VANI) Form 4 report any stock sales?
No stock sales are reported. The Form 4 shows only acquisitions via compensation awards: 200,000 stock options and 100,000 performance-based RSUs, both granted at a $0.00 transaction price per unit, subject to vesting conditions.